LRRK2 and Parkinson disease: To confirm whether O-αS-treated LRRK2 G2019S-Tg mice showed early parkinsonism-like behaviors, we evaluated gait performance and motor skill learning which might be affected by early synaptic dysfunction in PD pathogenesis.13